Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

NCT00553800

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • AtlantiCare Regional Medical Center Galloway, New Jersey, United States
  • Fox Chase Virtua Health Cancer Program at Memorial Mount Holly, New Jersey, United States
  • Paoli Hospital Paoli, Pennsylvania, United States
  • Abramson Cnacer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C

NCT03623750

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Hospital Universitario Insular de Gran Canaria Las Palmas de Gran Canaria, Canary Islands, Spain
  • Instituto Oncológico Dr. Rosell Barcelona, Spain
  • Hospital Clínic Barcelona Barcelona, Spain
  • Hospital Universitario Regional de Málaga Málaga, Spain
View Trial Details
Completed

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

NCT03102320

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 72 locations
View Trial Details
Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00097851

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Sydney Cancer Centre, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Sydney Haematology and Oncology Clinics Hornsby, New South Wales, Australia
  • Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
View all 13 locations
View Trial Details
Completed

Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00103389

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sydney Heamatology and Oncology Clinics Hornsby, New South Wales, Australia
  • Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Sydney Cancer Centre at Royal Prince Alfred Hospital Sydney, New South Wales, Australia
View all 13 locations
View Trial Details
Completed

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

NCT02648724

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 27 locations
View Trial Details
Completed

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

NCT00376623

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • 1216.9.49002 Boehringer Ingelheim Investigational Site Freiburg im Breisgau, Germany
  • 1216.9.49007 Boehringer Ingelheim Investigational Site Gauting, Germany
  • 1216.9.49008 Boehringer Ingelheim Investigational Site Großhansdorf, Germany
  • 1216.9.49001 Boehringer Ingelheim Investigational Site Heidelberg, Germany
View Trial Details

Related conditions